Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Equity (2021 - 2025)

Historic Return on Equity for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.48%.

  • Maravai Lifesciences Holdings' Return on Equity fell 100.0% to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.38% for FY2024, which is 2200.0% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Return on Equity is 0.48%, which was down 100.0% from 0.68% recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Return on Equity registered a high of 0.97% during Q2 2021, and its lowest value of 0.68% during Q2 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.19% (2023), whereas its average is 0.21%.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Return on Equity surged by 1900bps in 2022 and then plummeted by -7300bps in 2023.
  • Maravai Lifesciences Holdings' Return on Equity (Quarter) stood at 0.94% in 2021, then crashed by -40bps to 0.56% in 2022, then plummeted by -129bps to 0.16% in 2023, then crashed by -165bps to 0.44% in 2024, then dropped by -9bps to 0.48% in 2025.
  • Its Return on Equity was 0.48% in Q3 2025, compared to 0.68% in Q2 2025 and 0.52% in Q1 2025.